PRA Health Sciences (PRAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SmarTrend identified a Downtrend for Pra Health Scien (NASDAQ:PRAH) on June 11th, 2020 at $97.16. In approximately 2 weeks, Pra Health Scien has returned 2.49% as of today's recent price of $94.74.
In the face of the pandemic, the digital health management space continues to thrive on a number of positive developments.
U.S. law requiring clinical research for pediatric oncology treatments goes into effect mid-August 2020
PRA Health (PRAH) gives a boost to COVID-19 Monitoring program through collaboration with the Microsoft Healthcare Bot service.
PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today the enhancement of its commercial Health Harmony COVID-19 Monitoring Program with the integration of the Microsoft Healthcare Bot service. Users...
SmarTrend identified an Uptrend for Pra Health Scien (NASDAQ:PRAH) on April 9th, 2020 at $87.63. In approximately 2 months, Pra Health Scien has returned 16.81% as of today's recent price of $102.36.
, /PRNewswire/ -- The report has been added to offering.
Pra Health Scien (NASDAQ:PRAH) traded in a range yesterday that spanned from a low of $105.74 to a high of $109.36. Yesterday, the shares fell 3.2%, which took the trading range below the 3-day low of...
, /PRNewswire/ --
PRA Health Sciences (PRAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The global contract research organization services market size is expected to reach USD 90,926.3 million by 2026, exhibiting a CAGR of 11.4% during the forecast period. The increasing demand for effective...
PRA Health's (PRAH) Clinical Research segment puts up a strong performance in Q1.
PRA Health Sciences (PRAH) delivered earnings and revenue surprises of 0.96% and 3.04%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
RALEIGH, N.C. (AP) _ PRA Health Sciences Inc. (PRAH) on Thursday reported first-quarter profit of $40.7 million.
-- Net new business of $604.7 million; Net book-to-bill of 1.10 excluding reimbursement revenue
PRA Health Sciences (PRAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
PRA Health (PRAH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Let's keep a watch on three stocks that are focusing on digital health to fight against coronavirus.
PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its first quarter 2020 results after the market closes on Thursday, April 30, 2020. The Company will also host a conference call on Friday, May 1,...